Stocks To Buy Now

Blog


2022 Virtual Growth Conference to Feature Roundtables, Fireside Chats with 250+ Companies

Companies and investors are encouraged to attend the 2022 Virtual Growth Conference being held as a virtual gathering March 28-30, 2022. The Virtual Growth Conference, organized by Maxim Group LLC and hosted by M-Vest, will provide a unique opportunity for attendees to interact with institutional investors and executives from 250+ companies. This year’s gathering will feature leaders from a diverse collection of industry sectors, including biotech, clean energy, electric vehicles, financial services, fintech & REITs, gaming & entertainment, healthcare, healthcare IT, infrastructure, shipping and technology/media/telecom. To RSVP for your virtual seat, visit https://ibn.fm/2022VirtualGrowth The 2022 Virtual Growth Conference kicks off day one at 9:00 a.m. ET, offering two distinct tracks designed to keep attendees engaged and informed throughout the three-day gathering. Presenting companies will participate in fireside chats examining their operations and goals, and seasoned executives will take center stage for thought-provoking roundtable discussions moderated by Maxim research analysts. Conference Highlights
  • 250+ participating companies representing a variety of industry sectors
  • Live roundtable discussions and Q&A sessions with CEOs
  • 30-minute fireside chats with executives from emerging growth companies
  • Participation is open exclusively to M-Vest members (free registration option is available)
The Virtual Growth Conference brings all the benefits and face-to-face opportunities of traditional investor gatherings in a convenient virtual format, making it easy for executives, institutional investors and M-Vest members to interact and network without making travel plans. IBN (InvestorBrandNetwork) will be a gold sponsor of the conference and is helping maximize visibility for the event as a whole. Together, the conference’s organizers and sponsors aim to create an atmosphere that fosters business development opportunities and offers insight into emerging companies operating across a wide array of industries. To learn more, please visit https://ibn.fm/2022VirtualGrowth

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Reports Strong Results in ‘Real-World’ Trial

July 18, 2025

Soligenix (NASDAQ: SNGX) is reporting encouraging interim outcomes from the ongoing investigator-initiated study (“IIS”) of its HyBryte(TM) (synthetic hypericin) program, under the direction of Ellen Kim, MD, director of the Penn Cutaneous Lymphoma Program. Kim is a leading enroller in Soligenix’s phase 3 FLASH study and serves as principal investigator for the confirmatory phase 3 FLASH2 trial, […]

Rotate your device 90° to view site.